Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV

BACKGROUND: As the use of Integrase inhibitor (INSTI)-class antiretroviral medications becomes more common to maintain long-term viral suppression, early reports suggest the potential for CNS side-effects when starting or switching to an INSTI-based regimen. In a population already at higher risk fo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:AIDS Behav
Prif Awduron: Kamkwalala, Asante R., Wang, Kunbo, O’Halloran, Jane, Williams, Dionna W., Dastgheyb, Raha, Fitzgerald, Kathryn C., Spence, Amanda B., Maki, Pauline M., Gustafson, Deborah R., Milam, Joel, Sharma, Anjali, Weber, Kathleen M., Adimora, Adaora A., Ofotokun, Igho, Sheth, Anandi N., Lahiri, Cecile D., Fischl, Margaret A., Konkle-Parker, Deborah, Xu, Yanxun, Rubin, Leah H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948485/
https://ncbi.nlm.nih.gov/pubmed/32638219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-020-02967-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg